Cite
HARVARD Citation
Selaru, P. et al. (2016). Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib. Clinical and translational science. 9 (2), pp. 63-73. [Online].